Manufacturers benefit from learning more about the types of buildings architects working with MMC techniques can design.
They often do not carry the overhead of strategic teams, and there is an opportunity to share, promote and assist their move towards more efficient use of solvents through the sharing of insights and examples.The influence of the R&D led industry is hugely significant, providing the worked through case-studies and directly influencing their supply chain, including contract manufacturers.. Over the course of the discussion, there was a radical switch in the reflections on regulations and regulators.
At the outset, regulators were seen as one of the significant barriers to moving forward at speed.There was some evidence for this as changing a drug registration can take three years and has a significant cost attached to it.However, it is unclear how many registrations do more than specify a solvent and list suppliers.
If so, a change in source hypothetically is a small change.A biogenic source, meeting the specification, would require little or no change..
If only life was so simple.
Current concerns about low level impurities exacerbated by issues like the discovery of nitrosamine impurities in medicines.Do we really want to walk away from all that learning, and start moving as much of the construction process as possible into distant sheds?.
Is on-site construction really all that bad?.Construction sites could be defined as locations where finished assets are built.
They can be messy, congested, dirty and chaotic places.But they don’t have to be.
(Editor: Space-Saving Cables)